MIRA Pharmaceuticals, Inc. (MIRA)
1.51
+0.02
(+1.34%)
USD |
NASDAQ |
Dec 11, 13:29
MIRA Pharmaceuticals EPS Diluted (Quarterly): -1.177 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.69M |
| Total Expenses (Quarterly) | 22.69M |
| Enterprise Value | 54.86M |
| Earnings Yield | -100.8% |
| Normalized Earnings Yield | -101.21 |